Peter Sölkner
Vermögen: 23 722 $ am 31.08.2026
Vermögen: 23 722 $ am 31.08.2026
Mr. Peter Sölkner is a Founding Partner at Prime Radiant Partners SpA, a Managing Director at Vetter Pharma-Fertigung GmbH & Co. KG and a Co-Managing Director at Vetter Pharma-Fertigung Verwaltungs GmbH.
He is on the Board of Directors at Stevanato Group SpA, Oxford Biomedica Plc and Coriolis Pharma Research GmbH.
Mr. Sölkner was previously employed as a Principal by Sartorius AG, a Vice President by Sartorius Stedim Biotech SA, and a Managing Director by Vetter Pharma International GmbH.
He received his undergraduate degree from the University of Dortmund, a graduate degree from the University of Dortmund and an MBA from Columbia Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.09.2026 | 3 339 ( 0 % ) | 23 722 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 15.03.2024 |
| STEVANATO GROUP S.P.A. | Direktor/Vorstandsmitglied | 26.05.2026 |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides aseptically pre-filled syringes, cartridges and vials | Vorstandsvorsitzender | 01.06.2008 |
Vetter Pharma-Fertigung Verwaltungs GmbH
Vetter Pharma-Fertigung Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in providing manufacturing support services | Vorstandsvorsitzender | - |
Coriolis Pharma Research GmbH
Coriolis Pharma Research GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Vetter Pharma International GmbH
Vetter Pharma International GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Vorstandsvorsitzender | 01.05.2025 |
| SARTORIUS STEDIM BIOTECH | Corporate Officer/Principal | - |
| SARTORIUS AG | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Sartorius AG
Sartorius AG Medical SpecialtiesHealth Technology Manufactures instruments and appliances for measuring, testing and navigation | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Dortmund
University of Dortmund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides aseptically pre-filled syringes, cartridges and vials | Commercial Services |
Vetter Pharma-Fertigung Verwaltungs GmbH
Vetter Pharma-Fertigung Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in providing manufacturing support services | Commercial Services |
Stevanato Group SpA
Stevanato Group SpA Medical SpecialtiesHealth Technology Designs, manufacturers and supplies glass bottles and glass tube containers | Health Technology |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vetter Pharma International GmbH
Vetter Pharma International GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Coriolis Pharma Research GmbH
Coriolis Pharma Research GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen